BRPI0409511A - composto, composição farmacêutica, e, uso do composto - Google Patents

composto, composição farmacêutica, e, uso do composto

Info

Publication number
BRPI0409511A
BRPI0409511A BRPI0409511-1A BRPI0409511A BRPI0409511A BR PI0409511 A BRPI0409511 A BR PI0409511A BR PI0409511 A BRPI0409511 A BR PI0409511A BR PI0409511 A BRPI0409511 A BR PI0409511A
Authority
BR
Brazil
Prior art keywords
compound
pharmaceutical composition
transhydroxycycloexyl
pyrrolo
phenyl
Prior art date
Application number
BRPI0409511-1A
Other languages
English (en)
Inventor
Timo Heinrich
Axel Pahl
Bernd-Martin Luitjens
Emil Finner
Pieter C Verveer
Jan Zorgdrager
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of BRPI0409511A publication Critical patent/BRPI0409511A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSTO, COMPOSIçãO FARMACêUTICA, E, USO DO COMPOSTO". A presente invenção diz respeito ao novo composto de mesilato de hidrogênio de 4-(4-trans-hidroxicicloexil)amino-2-fenil-7H-pirrolo¢2,3d!pirimidina, as formas polimórficas <244> e <225> destes e um método para a produção dos ditos compostos.
BRPI0409511-1A 2003-04-22 2004-04-21 composto, composição farmacêutica, e, uso do composto BRPI0409511A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03101093 2003-04-22
PCT/EP2004/050573 WO2004094428A1 (en) 2003-04-22 2004-04-21 4-(4-trans-hydroxycyclohexyl)amino-2-phenyl-7h-pyrrolo`2, 3d! pyrimidine hydrogen mesylate and its polymorphic forms

Publications (1)

Publication Number Publication Date
BRPI0409511A true BRPI0409511A (pt) 2006-04-18

Family

ID=36143550

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0409511-1A BRPI0409511A (pt) 2003-04-22 2004-04-21 composto, composição farmacêutica, e, uso do composto

Country Status (26)

Country Link
US (1) US7381729B2 (pt)
EP (1) EP1641797B1 (pt)
JP (1) JP2006524214A (pt)
KR (1) KR20060021296A (pt)
CN (1) CN100360533C (pt)
AR (1) AR043880A1 (pt)
AT (1) ATE373002T1 (pt)
AU (1) AU2004232495B2 (pt)
BR (1) BRPI0409511A (pt)
CA (1) CA2522810A1 (pt)
DE (1) DE602004008919T2 (pt)
DK (1) DK1641797T3 (pt)
ES (1) ES2290696T3 (pt)
HK (1) HK1089767A1 (pt)
IL (1) IL171120A (pt)
MX (1) MXPA05011348A (pt)
NO (1) NO20055495L (pt)
PL (1) PL1641797T3 (pt)
PT (1) PT1641797E (pt)
RU (1) RU2345994C2 (pt)
SA (1) SA04250093B1 (pt)
SI (1) SI1641797T1 (pt)
TW (1) TWI324517B (pt)
UA (1) UA81806C2 (pt)
WO (1) WO2004094428A1 (pt)
ZA (1) ZA200508519B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR043880A1 (es) 2003-04-22 2005-08-17 Solvay Pharm Gmbh Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas
WO2007073855A1 (en) * 2005-12-23 2007-07-05 Bayer Healthcare Ag Use of adenosine a1 receptor agonists for the protection of renal cells against toxic effects caused by aminoglycosides during treatment of infectious diseases
TW200808819A (en) * 2006-06-19 2008-02-16 Solvay Pharm Gmbh Use of adenosine A1 antagonists in radiocontrast media induced nephrophaty
TWI561520B (en) * 2012-09-27 2016-12-11 Sunshine Lake Pharma Co Ltd Crystalline forms of dihydropyrimidine derivatives

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1254569A (en) * 1982-08-19 1989-05-23 Ian C. Pattison Sulfonic acid salts of 6-amino-1,5-dihydro-4h- imidazo¬4,5-c|pyridin-4-one
CS249455B1 (en) * 1985-01-24 1987-03-12 Miroslav Protiva N-substituted 2-chloro-7-fluoro-10-piperazino-10,11-dihydrodibenzo(b,f)thiepines and their salts and method of their preparation
JP2815691B2 (ja) * 1990-09-20 1998-10-27 麒麟麦酒株式会社 Ｋｒｎ２３９１酸付加塩およびその用途
FR2708604B1 (fr) * 1993-07-30 1995-10-20 Sanofi Elf Utilisation de dérivés de benzènesulfonyl-indole pour la préparation de médicaments.
JPH08198876A (ja) * 1995-01-30 1996-08-06 Yoshitomi Pharmaceut Ind Ltd トランス−Ｎ−（１Ｈ−ピラゾロ〔３，４−ｂ〕ピリジン−４−イル）−４−グアニジノメチルシクロヘキサンカルボキサミド・１メタンスルホン酸塩・１水和物
JPH08337584A (ja) * 1995-04-10 1996-12-24 Dai Ichi Seiyaku Co Ltd 縮合六環式アミノ化合物、これを含有する医薬及びその製法
FR2749846B1 (fr) * 1996-06-17 1998-09-11 Pf Medicament Sel de methanesulfonate d'une arylpiperazine derivee de tryptamine et ses solvates pour usage pharmaceutique
MA24500A1 (fr) * 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
DZ2805A1 (fr) 1998-06-02 2005-01-30 Cadus Pharmaceutical Corp Composition à pyrroloÄ2,,3dÜ pyrimidine et leurs usages.
US6878716B1 (en) * 1998-06-02 2005-04-12 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptor and uses thereof
TWI223598B (en) * 1998-06-22 2004-11-11 Pfizer Ireland Pharmaceuticals An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate
ATE335489T1 (de) * 1999-12-02 2006-09-15 Osi Pharm Inc Für adenosin a3, a2a und a3 rezeptoren spezifische verbindungen und deren verwendungen
PT1268468E (pt) * 2000-03-03 2004-01-30 Pfizer Mesilato de 4-amino-6,7dimetoxi-2- (5-metanossulfonamido-1,2,3,4-tetra-hidro-2-isoquinolil)5-5(2-piridil-quinazolina e polimorfos
WO2002032861A2 (en) * 2000-10-17 2002-04-25 Merck & Co., Inc. Orally active salts with tyrosine kinase activity
US6680324B2 (en) * 2000-12-01 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
US6673802B2 (en) * 2000-12-01 2004-01-06 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
AR043880A1 (es) 2003-04-22 2005-08-17 Solvay Pharm Gmbh Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas

Also Published As

Publication number Publication date
DE602004008919T2 (de) 2008-06-19
CN100360533C (zh) 2008-01-09
KR20060021296A (ko) 2006-03-07
US20040248912A1 (en) 2004-12-09
EP1641797B1 (en) 2007-09-12
NO20055495D0 (no) 2005-11-21
TWI324517B (en) 2010-05-11
RU2005136215A (ru) 2006-03-20
ATE373002T1 (de) 2007-09-15
DE602004008919D1 (de) 2007-10-25
WO2004094428A1 (en) 2004-11-04
MXPA05011348A (es) 2005-11-28
ES2290696T3 (es) 2008-02-16
UA81806C2 (uk) 2008-02-11
SI1641797T1 (sl) 2007-12-31
NO20055495L (no) 2006-01-23
PT1641797E (pt) 2007-12-21
CA2522810A1 (en) 2004-11-04
CN1777606A (zh) 2006-05-24
AU2004232495A1 (en) 2004-11-04
TW200505457A (en) 2005-02-16
DK1641797T3 (da) 2007-10-29
ZA200508519B (en) 2007-04-25
AU2004232495B2 (en) 2010-04-22
AR043880A1 (es) 2005-08-17
US7381729B2 (en) 2008-06-03
EP1641797A1 (en) 2006-04-05
JP2006524214A (ja) 2006-10-26
SA04250093B1 (ar) 2008-07-12
HK1089767A1 (en) 2006-12-08
RU2345994C2 (ru) 2009-02-10
IL171120A (en) 2011-01-31
PL1641797T3 (pl) 2008-01-31

Similar Documents

Publication Publication Date Title
HK1110588A1 (en) Novel phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase
TNSN07196A1 (en) Potentiators of glutamate receptors
ECSP077249A (es) Nuevos hidratos y polimorfos de 4-[[(7r)-8-ciclopentil-7-etil-5,6,7,8-tetrahidro-5-metil-6-oxo-2-pteridinil]amino]-3-metoxi-n-(1-metil-4-piperidinil)-benzamida, procedimiento para su preparación y su uso como fármaco
DK1337518T3 (da) Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren
BRPI0607455A2 (pt) composto, processo para a preparação do mesmo, uso de um composto, e composição farmacêutica
SE0101675D0 (sv) Novel composition
CY1106486T1 (el) Μεθοδος παρασκευης 2-(κινοξαλιν-5-υλσουλφονυλαμινο) βενζαμιδικων ενωσεων
MX2007007845A (es) Sulfonilpirrolidinas, metodo para producir las mismas y su uso como medicamento.
CY1109010T1 (el) γ-ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ ΙΒΑΒΡΑΔΙΝΗΣ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΤΗΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΕΧΟΥΝ
CY1109775T1 (el) Κρυσταλλικες μορφες μιας διφαινυλικης ενωσης
TW200716583A (en) Crystal forms of {[(2R)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
TW200638930A (en) Acetylene derivatives
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
TW200716568A (en) 1H-quinazoline-2,4-diones
BRPI0512986A (pt) novos derivados de hidantoìna
DE602005009977D1 (de) Tetralin- und indanderivate und deren anwendungen als 5-ht-antagonisten
TW200738649A (en) Calcilytic compounds
ATE374190T1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
BR0311984A (pt) Difenilazetidinonas substituìdas cationicamente, processo para a sua preparação, medicamentos contendo estes compostos e sua aplicação
BRPI0509384A (pt) processo de hidrogenação assimétrica para a preparação de um composto ou um sal do mesmo, e, composto ou um sal do mesmo
BRPI0417858A (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
DK1893589T3 (da) Substituerede N-benzo[d]isoxazol-3-yl-amin-derivater som inhibitorer af mGluR5-, serotonin-(5-HT) og noradrenalinreceptorer og deres anvendelse til fremstilling af lægemidler
SE0403085D0 (sv) Novel componds
WO2006079720A8 (fr) Nouveaux derives d1oximes heterocycliques, leur procede de preparation et leur utilisation comme agents hypoglycemiants et hypoli pemiants
BRPI0411308A (pt) composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA: INT. CL. C07D 487/04; A61P 9/00

Ipc: C07D 487/04 (2011.01), A61P 9/00 (2011.01)

B08L Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette]

Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 9A E 10A ANUIDADES.

B08I Publication cancelled [chapter 8.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2258 DE 15/04/2014 POR TER SIDO INDEVIDA.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 9A, 10A, 11A, 12A, 13A, 14A, 15A E 16A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.